论文部分内容阅读
目的建立职业性三氯乙烯药疹样皮炎(OMDT)临床路径。方法选择OMDT为临床路径的病种,在循证医学和临床资料分析的基础上,结合专家咨询和GBZ 185—2006《职业性三氯乙烯药疹样皮炎诊断标准》确定OMDT的诊断与治疗方案,制定临床路径文本,并进行初步临床验证。结果制定供医护人员使用的OMDT临床路径文本,包括标准住院流程(包括糖皮质激素的规范使用方案)、《临床路径表单》、《接受糖皮质激素治疗知情同意书》;制定供患者或其家属使用的患者版《临床路径告知书》。经初步临床验证,该临床路径有利于优化医疗流程,患者均无出现病情反跳和并发症,且患者对OMDT的认知程度和治疗的满意度均提高。结论 OMDT临床路径科学、合理,有利于规范医疗行为。
Objective To establish a clinical pathway of occupational trichlorethylene dermatitis (OMDT). Methods Based on evidence-based medicine and clinical data, combined with expert consultation and GBZ 185-2006 “diagnostic criteria for occupational trichlorethylene-like dermatitis”, OMDT was selected as the clinical pathology. OMDT was diagnosed and treated. Develop clinical pathway texts and conduct preliminary clinical validation. Results Development of OMDT clinical pathway texts for use by healthcare professionals, including standard hospitalization procedures (including normative use of glucocorticoids), “clinical pathway sheets”, “informed consent to receive glucocorticoid treatment”; development of guidelines for patients or their families Patient version used “clinical pathway advice.” After preliminary clinical validation, the clinical pathway is conducive to optimizing the medical process, patients did not appear rebound and complications, and patients with OMDT awareness and satisfaction were improved. Conclusion The clinical pathway of OMDT is scientific and reasonable, which is conducive to standardizing medical behaviors.